Description du projet
Maintenir l’Europe à l’avant-garde mondiale de la R&D en photonique
La science et la technologie de la lumière, la photonique, sont à l’origine de nombreuses innovations qui ont transformé notre vie quotidienne – de l’éclairage LED dans nos voitures, maisons et écrans d’ordinateur aux lasers et fibres optiques. Pour développer une stratégie industrielle européenne de photonique axée sur la communauté, le projet BestPhorm21, financé par l’UE, mobilisera plus de 3 000 experts de l’industrie et du monde universitaire. Ensemble, ils guideront Horizon Europe et les investissements industriels dans la R&D et la fabrication de pointe. Au final, le projet contribuera de manière décisive à accroître la souveraineté technologique européenne en photonique, une technologie numérique clé. Pour maintenir l’Europe à l’avant-garde mondiale de la R&D en photonique, BestPhorm21 lancera des investissements inter-États membres et régionaux.
Objectif
BestPhorm21 will provide the decisive support to Horizon Europe’s “Photonics Partnership”, which is currently established between the EU Commission and Photonics21, to stimulate the growth of the European photonics industry. The project is led by the Photoncs21 Secretariat, VDITZ, in partnership with 14 National Technology Platforms, representing Europe’s photonics industry, Research and Technology Organisations (RTOs) and clusters. BestPhorm21 will develop a community driven European photonics industrial strategy and roadmap, engaging over 3,000 experts from industry and academia, that will guide Horizon Europe and industrial investments in R&D and advanced manufacturing. BestPhorm21 thus makes a significant contribution to increasing European technological sovereignty in a key digital technology such as photonics. It will furthermore establish new strategic value chains between photonics and end user industries, through the delivery of 7 additional “photonics enabled” end user industry roadmaps. This will be done in close cooperation with the respective industry stakeholders organsiations, more than 700 experts from both the photonics and end-user industries will be involved. The industrial strategy will result in new product launches and services that drive sales growth and support the digitalization of these sectors. BestPhorm21 will trigger cross-member state and regional investments, which mobilise and leverage Europe‘s full innovation ecosystem to keep Europe at the global forefront in photonics R&D and technology development, delivering cross-member state calls valued at > EUR 10 m and 5 interregional investment projects. Finally, BestPhorm21 increases access to risk finance for over 300 photonics start-ups and SMEs in their critical growth phases, through “blended finance” (European Investment Council’s Accelerator), “Venture Capital” (dedicated VC events) and “Venture debt” (European Investment Bank).
Champ scientifique
Programme(s)
Régime de financement
CSA - Coordination and support actionCoordinateur
40468 Duesseldorf
Allemagne